Brooks Laboratories Ltd (BROOKS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 539063,
    "name": "Brooks Lab.",
    "stock_name": "Brooks Lab.",
    "full_name": "Brooks Laboratories Ltd",
    "name_url": "stocks-analysis/brooks-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "59.90",
    "chg": -0.11,
    "chgp": "-0.18%",
    "dir": -1,
    "prev_price": "60.01",
    "mcapval": "179.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533543,
    "symbol": "BROOKS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE650L01011",
    "curr_date": "Aug 10, 03:30 PM",
    "curr_time": "21:19 PM",
    "last_traded_at": "Aug 10, 03:30 PM IST",
    "bse_nse_vol": "16.08 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/brooks-lab-539063-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Brooks Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-brooks-laboratories-ltd-4142250",
        "imagepath": "",
        "date": "2026-08-07 23:18:37",
        "description": "The next results date for Brooks Laboratories Ltd is scheduled for 13 August 2026...."
      },
      {
        "title": "Brooks Laboratories Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-4139314",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_mojoScore_4139314.png",
        "date": "2026-08-06 08:09:01",
        "description": "Brooks Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 5 August 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. The pharmaceutical micro-cap’s latest quarterly results and long-term financial trends have failed to inspire confidence, while its technical profile has shifted further into bearish territory. This comprehensive analysis explores the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have driven this decisive rating change."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-sell-4130007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_mojoScore_4130007.png",
        "date": "2026-07-31 10:11:38",
        "description": "Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Lower Circuit With 4.52% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4119304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_stocks_hitting_lower_circuit_4119304.png",
        "date": "2026-07-24 11:00:10",
        "description": "At Rs 63.00, Brooks Laboratories Ltd found itself trapped at its lower circuit on 24 Jul 2026, with a 4.52% decline marking the maximum loss permitted by the 5% price band. Despite sellers lining up to exit, there were no buyers willing to absorb the supply, resulting in a frozen price and unfilled sell orders throughout the session."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-sell-4108920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_mojoScore_4108920.png",
        "date": "2026-07-20 10:10:58",
        "description": "Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Brooks Laboratories Ltd Upgraded to Sell on Improved Valuation and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-upgraded-to-sell-on-improved-valuation-and-financial-metrics-4094547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_mojoScore_4094547.png",
        "date": "2026-07-09 08:08:18",
        "description": "Brooks Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 8 July 2026, driven primarily by a significant improvement in its valuation metrics. Despite persistent challenges in financial performance and technical indicators, the company’s valuation grade has shifted from fair to very attractive, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Brooks Laboratories Ltd Valuation Shifts to Very Attractive Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-valuation-shifts-to-very-attractive-amid-market-challenges-4094210",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_valuationdot_4094210.png",
        "date": "2026-07-09 08:00:30",
        "description": "Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from a fair to a very attractive rating. Despite recent share price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling entry points compared to both its historical averages and peer group valuations."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Lower Circuit With 4.81% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4093845",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_stocks_hitting_lower_circuit_4093845.png",
        "date": "2026-07-08 15:00:14",
        "description": "At Rs 69.52, Brooks Laboratories Ltd found itself locked at its lower circuit limit of 4.81% on 08 Jul 2026, with persistent selling pressure overwhelming demand and leaving unfilled supply at the floor price."
      },
      {
        "title": "Below All Moving Averages and Now at Lower Circuit: Brooks Laboratories Ltd Loses 5.0% in a Single Session",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4092481",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_stocks_hitting_lower_circuit_4092481.png",
        "date": "2026-07-07 14:00:08",
        "description": "At Rs 73.03, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5.0% on 7 Jul 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity."
      }
    ],
    "total": 341,
    "sid": "539063",
    "stock_news_url": "https://www.marketsmojo.com/news/brooks-laboratories-539063"
  },
  "announcements": [
    {
      "details": "Brooks Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transactions for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "Brooks Laboratories Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Brooks Laboratories Limited has informed the Exchange regarding a press release dated November 15, 2019, titled \"Unaudited Financial Results for the 2nd quarter and half year ended 30.09.2019\".",
      "source": "NSE",
      "caption": "Brooks Laboratories Limited - Press Release",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Brooks Laboratories Limited has informed the Exchange regarding Reappointment of Auditor of the company.",
      "source": "NSE",
      "caption": "Brooks Laboratories Limited - Reappointment",
      "datetime": "25-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Brooks Laboratories Ltd has announced <strong>1:16</strong> rights issue, ex-date: 28 Jul 23",
          "dt": "2023-07-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

When is the next results date for Brooks Laboratories Ltd?

2026-08-07 23:18:37

The next results date for Brooks Laboratories Ltd is scheduled for 13 August 2026....

Read full news article

Brooks Laboratories Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-08-06 08:09:01

Brooks Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 5 August 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. The pharmaceutical micro-cap’s latest quarterly results and long-term financial trends have failed to inspire confidence, while its technical profile has shifted further into bearish territory. This comprehensive analysis explores the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have driven this decisive rating change.

Read full news article

Brooks Laboratories Ltd is Rated Sell

2026-07-31 10:11:38

Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Brooks Laboratories Ltd Locks at Lower Circuit With 4.52% Loss — Sellers Queue, No Buyers in Sight

2026-07-24 11:00:10

At Rs 63.00, Brooks Laboratories Ltd found itself trapped at its lower circuit on 24 Jul 2026, with a 4.52% decline marking the maximum loss permitted by the 5% price band. Despite sellers lining up to exit, there were no buyers willing to absorb the supply, resulting in a frozen price and unfilled sell orders throughout the session.

Read full news article

Brooks Laboratories Ltd is Rated Sell

2026-07-20 10:10:58

Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Brooks Laboratories Ltd Upgraded to Sell on Improved Valuation and Financial Metrics

2026-07-09 08:08:18

Brooks Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 8 July 2026, driven primarily by a significant improvement in its valuation metrics. Despite persistent challenges in financial performance and technical indicators, the company’s valuation grade has shifted from fair to very attractive, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector.

Read full news article

Brooks Laboratories Ltd Valuation Shifts to Very Attractive Amid Market Challenges

2026-07-09 08:00:30

Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from a fair to a very attractive rating. Despite recent share price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling entry points compared to both its historical averages and peer group valuations.

Read full news article

Brooks Laboratories Ltd Locks at Lower Circuit With 4.81% Loss — Sellers Queue, No Buyers in Sight

2026-07-08 15:00:14

At Rs 69.52, Brooks Laboratories Ltd found itself locked at its lower circuit limit of 4.81% on 08 Jul 2026, with persistent selling pressure overwhelming demand and leaving unfilled supply at the floor price.

Read full news article

Below All Moving Averages and Now at Lower Circuit: Brooks Laboratories Ltd Loses 5.0% in a Single Session

2026-07-07 14:00:08

At Rs 73.03, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5.0% on 7 Jul 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.

Read full news article

View All News